BCLI — Brainstorm Cell Therapeutics Share News
0.000.00%
Last trade - 00:00Brief: Brainstorm Cell Therapeutics Announces First Quarter 2023 Financial Results
Brainstorm Cell Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Cintas, Stryker, Zimmer Biomet Holdings
Brainstorm Cell Therapeutics falls on tanking cash reserves
Brainstorm Cell Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Brief: Brainstorm Cell Therapeutics Announces Full Year 2022 Financial Results
Brainstorm Cell Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Energy firms, crypto stocks, Walt Disney
U.S. STOCKS ON THE MOVE-Cyclerion, banks, Jounce Therapeutics
BrainStorm soars as FDA to review ALS therapy marketing application
U.S. STOCKS ON THE MOVE-Tesla, BrainStorm, Pinterest
BrainStorm up as FDA holds advisory meeting for ALS therapy
Brief: Brainstorm Cell Therapeutics Announces FDA Advisory Committee Meeting For Nurown® For The Treatment Of ALS
Brief: Brainstorm To Announce Fourth Quarter And Fiscal Year 2022 Financial Results And Provide A Corporate Update
Brief: Brainstorm Cell Therapeutics Enters Into Partnerships To Provide Public Access To Biospecimens From Study
Chief Executive Officer
Brief: Brainstorm Cell Therapeutics Says Type A Meeting With FDA Granted For NurOwn
Brief: Brainstorm Cell Therapeutics Submits Type A Meeting Request To U.S. Food And Drug Administration
Brainstorm Cell Therapeutics Inc reports results for the quarter ended in September - Earnings Summary